Literature DB >> 23785125

High density lipoprotein structure, function, and metabolism: a new Thematic Series.

Kerry-Anne Rye1.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23785125      PMCID: PMC3708354          DOI: 10.1194/jlr.E041350

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


× No keyword cloud information.
  9 in total

1.  Lipoproteins in atherosclerosis.

Authors:  H B JONES; J W GOFMAN; F T LINDGREN; T P LYON; D M GRAHAM; B STRISOWER; A V NICHOLS
Journal:  Am J Med       Date:  1951-09       Impact factor: 4.965

2.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

Authors:  Tomas Vaisar; Subramaniam Pennathur; Pattie S Green; Sina A Gharib; Andrew N Hoofnagle; Marian C Cheung; Jaeman Byun; Simona Vuletic; Sean Kassim; Pragya Singh; Helen Chea; Robert H Knopp; John Brunzell; Randolph Geary; Alan Chait; Xue-Qiao Zhao; Keith Elkon; Santica Marcovina; Paul Ridker; John F Oram; Jay W Heinecke
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

3.  Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.

Authors:  J J Badimon; L Badimon; V Fuster
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

5.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

6.  Major lipids, apolipoproteins, and risk of vascular disease.

Authors:  Emanuele Di Angelantonio; Nadeem Sarwar; Philip Perry; Stephen Kaptoge; Kausik K Ray; Alexander Thompson; Angela M Wood; Sarah Lewington; Naveed Sattar; Chris J Packard; Rory Collins; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2009-11-11       Impact factor: 56.272

7.  High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.

Authors:  D J Gordon; J Knoke; J L Probstfield; R Superko; H A Tyroler
Journal:  Circulation       Date:  1986-12       Impact factor: 29.690

8.  Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

Authors:  E M Rubin; R M Krauss; E A Spangler; J G Verstuyft; S M Clift
Journal:  Nature       Date:  1991-09-19       Impact factor: 49.962

9.  Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Authors:  Gregory G Schwartz; Anders G Olsson; Markus Abt; Christie M Ballantyne; Philip J Barter; Jochen Brumm; Bernard R Chaitman; Ingar M Holme; David Kallend; Lawrence A Leiter; Eran Leitersdorf; John J V McMurray; Hardi Mundl; Stephen J Nicholls; Prediman K Shah; Jean-Claude Tardif; R Scott Wright
Journal:  N Engl J Med       Date:  2012-11-05       Impact factor: 91.245

  9 in total
  3 in total

Review 1.  The Difference Between High Density Lipoprotein Subfractions and Subspecies: an Evolving Model in Cardiovascular Disease and Diabetes.

Authors:  W Sean Davidson; Allison L Cooke; Debi K Swertfeger; Amy S Shah
Journal:  Curr Atheroscler Rep       Date:  2021-03-27       Impact factor: 5.113

2.  The pleiotropic vasoprotective functions of high density lipoproteins (HDL).

Authors:  Guilaine Boyce; Emily Button; Sonja Soo; Cheryl Wellington
Journal:  J Biomed Res       Date:  2017-05-26

3.  Plasma Cathepsin S is Associated with High-density Lipoprotein Cholesterol and Bilirubin in Patients with Abdominal Aortic Aneurysms.

Authors:  Bosa Mirjanic-Azaric; Novak Vasic; Darko Cerne; Janko Kos; Natasa Bogavac-Stanojevic
Journal:  J Med Biochem       Date:  2019-05-11       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.